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ABSTRACT
Over the last 35 years, there has been dramatic progress
in the technology and applicability of percutaneous
techniques to treat obstructive coronary heart disease.
Percutaneous coronary intervention (PCI) has a
considerable evidence base and it is firmly established as
the most common procedure used in the invasive
treatment of patients with coronary heart disease in the
UK. This set of guidelines aims to address specifically
issues relating to PCI and not the growing subspecialty
of structural heart disease intervention. It is not intended
to provide a review of the entire evidence base for
coronary intervention. The evidence base relating to PCI
is extensively reviewed in international guidelines and
the British Cardiovascular Intervention society endorses
these guidelines and their updates. The guidelines
presented here focus on issues pertinent to practice
within the UK and set out a recommended template to
ensure optimal delivery of patient care.
INTRODUCTION
Over the last 35 years, there has been dramatic pro-
gress in the technology and applicability of percu-
taneous techniques to treat obstructive coronary
heart disease (CHD). Percutaneous coronary inter-
vention (PCI) has a considerable evidence base and
it is firmly established as the most common proced-
ure used in the invasive treatment of patients with
CHD in the UK.
In a field where technology continues to
develop rapidly, it is essential that centres under-
taking PCI are appropriately equipped, for staff
to be competent and for case selection to be
matched to the skill of the operators. This is the
fourth set of guidelines produced by the British
Cardiovascular Intervention Society (BCIS) and
the British Cardiovascular Society (BCS) and it
replaces the Guideline published in 2005.
Considerable developments have occurred during
the last 10 years including the widespread appli-
cation of emergency primary PCI (PPCI) for
treatment of patients with ST segment elevation
myocardial infarction (STEMI). Providing com-
prehensive data remains an essential requirement
both for the centres and operators performing
PCI. The BCIS audit of adult interventional pro-
cedures, run in collaboration with the National
Institute for Cardiovascular Outcomes Research
(NICOR) allows each patient’s outcome to be
tracked through his or her individual cardiac
journey from birth until death, in turn enabling
the UK’s national data to be analysed, presented
and reviewed. Within the last year individual PCI
operator outcomes of PCI procedures have been
published in the public domain.
There has been a slowing in the previously expo-
nential increase in rate of PCI in the UK within the
last few years. The need for emergency cardiac
surgery following failed angioplasty remains, but
this is now very infrequent. A large proportion of
PCI is undertaken without on-site surgery and the
linkage of these sites within Cardiac Networks
remains fundamental to the delivery of optimal
patient care, particularly when considering surgical
revascularisation options. A common standard is
applied in assessing a site’s suitability for the per-
formance of PCI and this is independent of the
provision of on-site surgery. Sites performing emer-
gency PPCI have specific requirements which
exceed those of sites performing only selected
elective and urgent cases.
This set of guidelines aims to address specifically
issues relating to PCI and not the growing subspe-
cialty of structural heart disease intervention. It is
not intended to provide a review of the entire
evidence base for coronary intervention. The
evidence base relating to PCI is extensively
reviewed in international guidelines and BCIS
endorses the guidelines issued by the European
Society of Cardiology (ESC) and the American
Heart Association (AHA) and their updates.1 2
The guidelines presented here focus on issues per-
tinent to practice within the UK and set out a
recommended template to ensure optimal delivery
of patient care.
STANDARDS
Institutional facilities
A centre performing PCI requires at least one
cardiac catheterisation laboratory. As there will be
inevitable equipment failures—a second catheterisa-
tion laboratory is ideal to provide an uninterrupted
service. In the absence of a functional second
cardiac catheterisation laboratory—a non-cardiac
radiological facility used for general radiology
backup or a high resolution portable fluoroscopy
unit with a small image intensifier is considered the
minimum requirement.
Contemporary archiving in a Digital Imaging and
Communications in Medicine compatible format is
mandatory and it should be stored and accessible
for a minimum of 8 years. Angiograms should be
stored securely on a database allowing ready access
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during emergencies. PCI centres remote from surgical centres
should have facilities for real-time image transfer to facilitate
discussion and advice about individual patients’ cases. Ideally
clinical networks should invest in secure information technology
that allows any neighbouring site in the region to view archived
patient data as this would facilitate optimal emergency care.
Physiological measurements including accurate pressure
recording and display of the waveforms on multiple simultan-
eous channels along with the facility to display and record a
range of ECG lead configurations are required. Patients who
have received sedation and/or analgesia should have their heart
rate and oxygen saturation monitored continuously throughout
the procedure.
Full resuscitation facilities including a defibrillator, intra-
aortic balloon counter-pulsation and an anaesthetic machine
should be readily available in all catheterisation laboratories
undertaking PCI. Facilities for monitoring anticoagulation (eg,
activated clotting time) and blood gas analysis should be avail-
able within the catheterisation laboratory complex. A wide
range of disposable angioplasty equipment including guide
catheters, guide wires, balloons and stents must be available at
all times and an appropriate method of inventory and stock
control is mandatory. Availability of covered stents to treat
perforation, pericardiocentesis sets to treat tamponade and an
accessible echocardiography machine is mandatory. Recent
technological advances have resulted in the availability of
many additional tools including intravascular ultrasound
(IVUS), optical coherence tomography (OCT), flow and pres-
sure wires and equipment for laser and/or rotational atherect-
omy. The role of pressure wire in functional evaluation of
coronary lesions is well established. This technology together
with IVUS forms an essential part of interventional diagnostic
procedures and should be available in catheter laboratories
performing coronary interventions.
Radiation protection
All catheter lab staff should be aware of the latest guidelines on
radiation protection. A representative of the radiation protection
officer—usually a radiographer—should ensure that all staff
comply with appropriate monitoring and that lead screens,
aprons, glasses and other methods of radiation shielding are
available and used appropriately. Monitoring of individual dose
exposure is mandatory along with feedback of the cumulative
dose.
Radiation risks from cardiac procedures should be dis-
cussed with the patient as part of the pre procedure consent
process.3 It is good practice to include the hazards associated
with radiation exposure on the consent form for PCIs.
Almost all the current catheter lab radiography sources are
equipped with methods to calculate and record peak skin
dose and dose area product. Recording of the patient’s dose
exposure is mandatory and measures should be in place to
recognise patients requiring multiple high dose exposures (eg,
computed tomography pulmonary angiogram (CTPA) fol-
lowed by PCI). The radiographer should notify the operator
where radiation exposure is above the notification threshold
(2000 mGy for first notification and subsequent notifications
at every 500 mGy increments3). The patient should be noti-
fied if the peak skin dose exceeds 3000 mGy in order to
highlight awareness of potential physical consequences. Many
institutions have developed skin dose cards to notify the
patient of the high dose exposure, which also details the
warning symptoms and contact details for further advice.4
Key points: institutional facilities
▸ Two cardiac dedicated catheter laboratories are the minimal
requirement for a PCI service undertaking emergency cases.
▸ Digital Imaging and Communications in Medicine archiving
of images.
▸ Physiological assessment facilities in all interventional
laboratories.
▸ Radiation protection mandatory.
Institutional volume
Although PCI could be considered as a routine procedure, it
requires an experienced multidisciplinary team that can provide
high quality care throughout the hospital stay. There has been
extensive debate about what should be regarded as the
minimum number of annual cases required for both institutions
and individuals to maintain optimal performance. In the guide-
lines published in 2000, 200 procedures per annum was set as
the standard for institutions,5 but since 2005 a minimum of 400
procedures per annum has been regarded as a minimum.6
These guidelines endorse and maintain the minimum centre
volume of >400 procedures per annum. Recent NICOR data
confirms the safety of these recommendations in current UK
practice but BCIS recognises that this recommendation will
require review with continued evolution of PCI techniques.
In 2013, 2 out of 98 National Health Service (NHS) units
and 18/19 private units in the UK were undertaking less than
200 procedures per annum. Twenty-two out of 98 were per-
forming less than 400 procedures per annum. Centres perform-
ing fewer than 200 procedures per annum for three
consecutive years have been named and contacted by BCIS.
BCIS continues to recommend the same facilities and standards
for both NHS and private hospitals with a minimum recom-
mended volume of 400 interventional cases per year. In the
future, every centre performing <400 cases per year will be
contacted by BCIS who will notify NHS England and the
Commissioners of sites whose practice is outside the recom-
mended volume guideline.
Interventional diagnostic procedures
There are considerable data supporting the role of physiological
assessment of stenosis using pressure wire prior to interven-
tion.7–10 There is also data on the use of cross-sectional imaging
with IVUS or OCT to measure lumen area and guide PCI.11 Use
of pressure wire and use of IVUS/OCT are regarded as interven-
tional diagnostic procedures by BCIS which endorses the use of
these techniques in appropriate cases. Interventional diagnostic
interventional cases should be performed in PCI centres with
full interventional cardiology capability and by accredited inter-
ventional cardiologists able to treat any complications which
might occur, for example, coronary dissection.
Interventional team numbers
The minimum recommended number of trained interventional
cardiologists within a PCI centre is three. Some centres have
used joint cover arrangements with neighbouring centres to
facilitate the initiation of the service. This arrangement should
be regarded as temporary and there is an expectation that a
third local permanent colleague will be appointed within
2 years.
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PPCI for STEMI—PPCI
Specific standards required for centres that provide emergency
PPCI for patients with STEMI have been developed by the
Clinical Reference Groups. It is expected that Trusts should
comply with all recommendations.
These BCIS guidelines recommend that patients undergoing
PPCI should be treated in 24/7 PCI centres treating more than
300 PPCI patients per annum. In view of geographical isolation,
this case volume may be impractical in some isolated areas but
BCIS suggests that for the UK, PPCI centres should all perform
an absolute minimum of 100 PPCI procedures per annum.
Centres performing <300 PPCIs/annum should consider annu-
ally whether a Network approach which rationalises the number
of adjacent PPCI centres would be a more appropriate model of
care.
A PPCI centre should have two or more cardiac catheter
laboratories and will require a larger catheter lab team to staff a
manageable rota. PCI operators should regard their contribution
to a PPCI rota as a fundamental part of their job plan. It is
recognised that this will necessitate cooperation between trusts
with regards to cross-charging, back-filling of duties at the base
hospital and compensatory rest.
Ultimately a sustainable PPCI rota for Consultant
Cardiologists should comprise a minimum of 6 Interventional
Cardiologists and ideally 10.
Key points: institutional volume
▸ Minimum centre volume is 400 cases/year.
▸ Minimum of three interventional cardiologists per centre.
▸ PPCI centres should have at least two catheter laboratories
and 24/7 provision of service for STEMI.
▸ PPCI centres should perform an absolute minimum of 100
STEMI/PPCI cases/year.
Surgical cover standards
BCIS fully supports the provision of PCI in appropriately
selected patients in centres without on-site cardiac surgery, pro-
vided standard centre and operator requirements as described in
this document are satisfied.
PCI without on-site cardiothoracic surgical cover is com-
monly performed in the UK. Emergency transfer for surgical
intervention has come down significantly since the advent of
intracoronary stents. While, 2.6% of patients undergoing PCI
required emergency coronary artery bypass grafting (CABG) in
1991,6 this has come down to 1.1% by 2007 and the latest
BCIS audit data showed 0.05% patients required emergency
transfer for surgical revascularisation in 2012.12 The eventual
outcome in these patients would have been different without
emergency surgical intervention.
Therefore, PCI centres without on-site surgical cover should
have a viable protocol for emergency transfer to the nearest sur-
gical centre. The protocol must be agreed by all stakeholders,
including the relevant parties in the non-surgical centre and the
surgical centre with which it works, local networks, commis-
sioners, and the ambulance service. The protocol will need to
address the training and availability of staff to accompany the
patient, including an anaesthetist when required. Emergency
transfer of patients should occur within a maximum of 1 h,
with the ability to start cardiopulmonary bypass within 2 h of
the call for surgical intervention.13 Necessary equipment should
also be considered, including a transportable intra-aortic balloon
counter-pulsation pump (IABP). BCIS recommends that the
feasibility of ambulance transfer of the IABP be tested to
confirm it can be achieved within the required 120 min timeline.
A good working relationship with the cardiac surgical team in
the surgical centre is essential for all non-surgical PCI centres. It
is considered good practice to undertake a virtual run (without
the requirement for actual ‘blue light’ driving) of a catheter lab
to surgical centre transfer with IABP annually.
Off-site surgery
In the UK the number and proportion of centres performing
PCI without on-site surgery continues to increase year-on-year,
and is now in the majority. In 2013 there were 69 non-surgical
PCI centres and 48 surgical centres. In all 37 008 PCI proce-
dures were undertaken in units without on-site cardiac surgery,
representing 40% of total UK activity. Within the current AHA/
American College of Cardiology PCI guidelines, published in
2011, there is a Class IIa recommendation for PPCI in hospitals
without on-site surgery, whereas the guidelines give only Class
IIb support for non-PPCI, stating that “Elective PCI might be
considered in hospitals without on-site cardiac surgery, provided
that appropriate planning for programme development has been
accomplished and rigorous clinical and angiographic criteria are
used for proper patient selection”.14 In fact, since these guide-
lines were written, two major multicentre randomised con-
trolled trials have been reported, and both support the safety of
non-PPCI in hospitals without on-site cardiac surgery. In the
CPORT-E trial, 18 867 patients were randomised 3:1 to
undergo PCI in centres with off-site surgery versus on-site
surgery.15 There was no difference in the primary safety end
point of 6-week mortality (0.9% vs 1.0%), nor in the incidence
of emergency CABG (0.1% vs 0.2%). Mortality in those
patients who underwent emergency surgery was also no differ-
ent between the non-surgical (2/13, 15.4%) and surgical (2/10,
20%) centres. However, procedural success was lower in non-
surgical centres (90.7% vs 91.4%, p=0.007), and target vessel
revascularisation was higher after 12 months (6.5% vs 5.4%,
p=0.01). More recently the MASS COM trial randomised 3691
patients undergoing non-PPCI 3:1 to be treated in non-surgical
or surgical centres.16 Again there was no difference in the
primary safety end point of 30-day major adverse cardiac events
(MACE) (9.2% vs 9.1%), nor in the need for emergency CABG
(0.3% vs 0.1%). In contrast to Cardiovascular Patient Outcomes
Research Team-E trial (CPORT-E) there was also no difference
in procedural success or in 12-month outcomes including target
vessel revascularisation (TVR). It is difficult to translate the find-
ings of these studies directly to UK practice given the substantial
differences in the organisation of services, in particular very low
volume non-surgical centres (117/year in MASS COM, 150/year
in CPORT-E) but staffed, at least in CPORT-E, by operators all
of whom were practising in surgical centres as well as non-
surgical centres, and whose individual PCI volumes were identi-
cal to those of the surgical centre interventionists. Nonetheless,
they provide solid support for non-emergency PCI in centres
without on-site surgery. Furthermore, a very large meta-analysis
including 914 288 patients undergoing non-PPCI in a number
of European as well as North American centres also showed no
difference in crude rates of inhospital mortality or emergency
CABG between patients treated in hospitals with off-site surgery
versus on-site surgery, although after adjustment for publication
bias, the risk of inhospital death was reported to be higher by
the investigators (OR 1.25, p=0.04).17
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Key points: surgical cover
▸ Surgical cover arrangements must be annually confirmed
and carefully documented.
▸ A maximum delay of 120 min from call to institution of
cardiopulmonary bypass is the required standard.
▸ Annual virtual practice runs with IABP in situ are
recommended practice.
Staff standards
Non-medical Cath Lab staff numbers and roles
The number of non-medical trained staff involved in a PCI pro-
cedure will depend on skill mix, complexity of the procedure
and the number of medical staff involved. BCIS recognises the
fundamental requirement of effective teamwork in optimising
patient outcome and the multidisciplinary team is represented
within BCIS by the Allied Professionals Working Group.
In most circumstances and in the absence of multiskilled prac-
titioners, it is recommended that there is a minimum of two
nurses per cath lab and one floater (one nurse at least band 5
and above) per shift for PCI procedures. In addition, one radi-
ographer and one physiologist per lab (usually band 6 and
above) would be considered normal practice. For units with
more than one catheter lab, a separate additional coordinator
should be considered (band 6 and above). Procedural roles are
suggested below (table 1).
All staff should have a period of supervision and fulfil a
competency-based training scheme within their hospital. There
are currently no national competency guidelines for PCI specif-
ically but documentation of completion of specified local train-
ing should be accessible. An Advanced Life Support certificate
should be held by all senior members of the Cath Lab team. All
other members of the team should hold a minimum of an inter-
mediate life supoort (ILS) certificate and all be versed in emer-
gencies within the Cath Lab. All members of the Cath Lab team
should be familiar with the local rules and guidelines for radi-
ation protection.
Patient care and consent
Patient preparation, informed consent and ward checklists
should be performed as part of local standard operating policies.
Attention should also be paid to issues which may affect the
patient’s ability to lie comfortably during the case.
Consent
The General Medical Council and good clinical practice
demands that patients are fully involved in the decisions about
their care. Consequently an operator should be satisfied that the
patient has been fully informed about the benefits and risks of
any interventional procedure. Formal signing of the consent
form may be delegated to a suitably trained and qualified
person only if they have sufficient knowledge of the proposed
procedure, and understand the risks involved. Patients must be
fully involved in the decisions about their care including details
of the procedure, benefits, procedural risks and likelihood of
success. Ample time should be allocated to allow the patient to
understand and discuss this information. All potential serious
adverse outcomes must be explained including the possibility of
death, acute myocardial infarction (MI), stroke, the requirement
for emergency cardiac surgery and complications of vascular
access. The likelihood of such events should be drawn from
local and/or national statistics and will vary depending on
the clinical scenario. The website http://www.gmc-uk.org/
guidance/ethical_guidance/consent_guidance_index.asp provides
the Gemeral Medical Council (GMC) guidance ‘Consent:
patients and doctors making decisions together’.
Written consent is advised for all PCI procedures except in an
emergency (1) when verbal consent may be taken together with
full documentation in the case notes or when (2) it is either not
possible to find out the patient’s wishes or the patient lacks the
capacity to give consent. Therefore, even in the setting of PPCI,
some form of either written consent or postprocedural written
record of consent is recommended.
A record of the consent form should be kept in the notes and
given to the patient.
WHO checklist
In addition to ward-based checklists, the National Patient
Safety Agency has asked all hospitals in England and Wales
to implement a five-stage checklist for all interventional proce-
dures based on the WHO safe surgery checklist (http://www.
nrls.npsa.nhs.uk/resources/collections/10-for-2010/five-steps-to-
safer-surgery/?entryid45=92901). Versions appropriate for
catheter lab use include local adaptations, the interventional
radiology checklist (approved by the National Patient Safety
Agency) and a version endorsed by the BCS.
Table 1 Procedural roles of non-medical catheter lab staff
Procedural roles Nurse Radiographer Physiologist Multiskilled practitioner
Checklist/checking into lab X X X X
Lead on safe surgery X X X X
Scrub X X
Circulate X X
Monitor haemodynamics X X X
Radiation protection X X X X
Sedation/intravenous administration X X
Cannulation X X X
Access site closure X X
Infection control X X X X
Documentation X X X X
Handover X X
Lab preparation/cleaning X X X X
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The five stages are:
1. Team brief: All members of the team meet before the start
of the list to discuss the requirements of the day’s list. Safety
issues such as patient allergies and comorbidities are dis-
cussed as well as potential procedural difficulties. Equipment
that may be needed is discussed.
2. Sign in: On receipt of each patient into the cath lab, check
identification, consent, allergies, pregnancy disclaimer (female
11–55 years), renal function, local preprocedure checklist.
May be performed by a nurse, radiographer or physiologist.
3. Time out: Before start of each procedure (can be performed after
draping, but before local anaesthetic) with all team members
taking part including the operator. Involves further check of
‘right patient/right procedure/right route’, consent, allergies and
safety for the team—including lead aprons and doors locked.
4. Sign Out: At the end of the procedure two practitioners
ensure the procedure has been documented fully and
detailed handover given including any recovery issues.
Address safety issues including sharps counted, swabs
counted, and identify any equipment problems/stock issues.
5. Debrief: At the end of the list, a discussion to identify good
and learning points, answer questions from team members,
promote learning and development of the team and discuss
any incidents and identify prevention strategies.
Analgesia/sedation
The majority of PCI procedures can be safely performed
without any sedation or under conscious sedation, administered
without the need for an anaesthetist. This requires the patient to
be responsive to verbal and tactile stimuli throughout the pro-
cedure. Each Catheter Lab should have a conscious sedation
policy and competencies which should be achieved and signed
off before any nurse/practitioner gives conscious sedation.
Carbon dioxide levels may rise under conscious sedation, par-
ticularly when procedures are prolonged and supplementary
oxygen is given in patients with lung disease or sleep apnoea. In
these clinical situations, capnography and/or anaesthetic support
should be considered.
Postprocedural care
After completion of the PCI procedure the patient is transferred to
either a ward or recovery area. Full details of the procedure,
details of the drugs administered during the procedure, and
recommendations for drug therapy thereafter, together with com-
plete procedural documentation should be handed over to the
receiving area staff. Subsequent nursing care should include obser-
vation of the point of vascular access, and haemodynamic and
ECG monitoring. A suggested scheme is included below (table 2).
Before discharge from hospital the patient with PCI should be
given written instructions relating to possible vascular and other
complications and advice on activity during the recovery period
including driving, etc. Arrangements should include a schedule
for return to work and proposed follow-up along with drug
therapy instructions and planned interactions with formal
cardiac rehabilitation programmes. Patient advice cards which
outline the prescribed dual antiplatelet regime and a contact
telephone number are valuable.
Routine measurement of biomarker/cardiac enzymes after PCI
In patients with acute coronary syndrome (ACS), biomarker ele-
vation before the PCI procedure occurs regularly. Consequently
interpretation of elevated biomarkers troponin, creatinine kinase
myocardial band (CKMB) post procedure is difficult and meas-
urement in ACS patients is not recommended. However, in
patients with stable angina undergoing elective PCI measure-
ment of biomarkers at an appropriate interval (4–6 h when
troponin is being measured) after the procedure is valuable and
this is considered to be best clinical practice.
Key points: staff standards/patient care and consent
▸ Minimum staffing levels: two nurses per catheter procedure.
▸ Operators should be satisfied that the patient has been fully
informed about the benefits and risks of any interventional
procedure. This must be confirmed with a written consent
form or in the notes.
▸ The WHO checklist or a local equivalent is mandatory.
Operators
A successful interventional cardiologist requires a combination
of manual dexterity and clinical judgement. Appropriate
Table 2 Postprocedural care, monitoring and observations
Radial
Successful (without complication) using
femoral access with device closure
Successful (without complication) using
femoral access—manual haemostasis
Elective
angiography
Observations/access site check every 15–30 min
for 1st h. Mobilise immediately if no sedation.
Discharge after 2 h
Observations/access site check every 15–30 min
for 1st h. Mobilise after 30 min. Discharged min
2–3 h
Observations/access site check every 15–30 min
for 1st h. Supine 1 h, sitting 2 h; mobilise 3 h.
Discharge min 3–4 h
Day case PCI No ECG monitoring unless stated. Single
12-lead ECG post procedure. Observations/
access site check every 15–30 min for 1st h,
then repeated at 2 h. Mobilise when sedation
worn off. Discharged at minimum 4 h
No ECG monitoring unless stated. Single 12-lead
ECG. Observations/access site check every 15–
30 min for 1st h, then repeated at 2 h. Mobilise
>60 min and after sedation worn off. Discharge
minimum 4 h
No ECG monitoring unless stated. Single
12-lead ECG. Arterial sheath removed ACT
<150 s. Observations/access site check every
15–30 min pre and post sheath removal.
Discharge minimum 5–6 h
Complex PCI—
elective
Cardiac monitoring required, post procedure
12-lead ECG. Observations and access site
check every 15–30 min for as long as required.
Mobilise when appropriate. Patients may require
overnight stay, discharged following day
Cardiac monitoring required, post procedure
12-lead ECG. Observations and access site check
every 15–30 min for as long as required. Mobilise
when appropriate. Patients may require overnight
stay, discharged following day
Cardiac monitoring required. 12-lead ECG post
procedure. Arterial sheath removed when ACT
<150 s. Observations and access site check
every 15–30 min for as long as required.
Patients may require overnight stay, discharged
following day
Inpatient PCI
(urgent NSTEMI/
STEMI)
Cardiac monitoring required for STEMI patients and patients with haemodynamic compromise during the procedure. Post procedure 12-lead ECG. It is
recommended that access site and patient checked every 15–30 min for as long as required. Bed rest as per hospital protocol
ACT, activated clotting time; NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction.
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emphasis is required on both the practicalities of the technique
and the procedural numbers but also recognition of the role of
overall patient assessment and balancing the risk-to-benefit
ratio. It remains axiomatic that maintenance of the practical
skills necessary for interventional cardiology requires the
regular performance of procedures to maintain those skills.
Debate is inevitable when setting an arbitrary minimum
number of procedures required by an individual to maintain
competence as an independent PCI operator. BCIS defines an
independent PCI operator as an individual who can decide on
PCI, plan the strategy and perform the case without consulting
any other operator, buddy, mentor or trainer.
Previous guidelines recommend a minimum of 75 PCI pro-
cedures per year for independent operators. This did not
include interventional diagnostic only procedures, which are
defined as the use of Fractional Flow reserve (FFR), IVUS and
OCT (and optical frequency domain imaging) when no PCI
ensues. Although there is insufficient evidence to change the
minimum number of total procedures as an appropriate ideal,
it is recognised that interventional diagnostic procedures do
use a subset of the practical skills needed for PCI.
Consequently the recommended combined case volume over
2 years is a minimum of 150 cases which can include up to a
maximum of 30 interventional diagnostic procedures (includ-
ing a mix of elective and non-elective patients).
There is no specified minimum volume for operators
undertaking PPCI. However it is recognised that these
patients are among the most challenging patients and that
familiarity with teamwork is essential. Consequently opera-
tors participating in PPCI cases should undertake an absolute
minimum of >50 elective/emergency cases/annum within
the emergency PPCI site and a total workload of at least
120 PCI cases plus up to 30 interventional diagnostic
procedures.
For Consultants or independent Specialist registrar (SPR)
operators who fulfil the guideline of 150 total procedures
over 2 years and who then are absent from practice for less
than 6 months—no additional training is required. If the
period of absence exceeds 6 months and is less than 2 years a
buddy system should be employed for 20–50 PCI procedures
(proportional to the period of absence exceeding 6 months)
before the operator becomes fully independent again.
Appointment of the buddy should be agreed by the regional
PCI training director.
Operators who have fully trained but have not undertaken
any procedures for 2 years or more should perform at least 75
PCI procedures with a mentor. This designated mentor should
formally assess the ability, aptitude and clinical judgement of the
operator.
Cardiologists who have never been trained in PCI and wish to
start PCI should undergo a full formal interventional training
programme.
Individual cardiologists who undertake PCI on multiple
sites are responsible for making sure that data from all the
sites are sent to NICOR where the data can then be aggre-
gated and provided back to them for appraisal and revalid-
ation.18 Only one operator can ultimately be responsible for a
PCI case although two Consultant Cardiologists may scrub
together. It is recommended that it is clarified before the initi-
ation of the case which consultant is responsible for the case
and the outcome. In cases of debate it is recommended that
the consultant with the lowest GMC number is recorded (this
will be the physician registered longest with the GMC) as the
default operator.
Key points: operator standards
▸ Diagnostic interventional cases are pressure wire/OCT (and
optical frequency domain imaging) or IVUS cases.
▸ Total procedural volume for PCI operators within a 2-year
period is a total of 150 cases (can include up to 30
diagnostic interventional cases).
▸ Operators participating in PPCI cases should be undertaking
an absolute minimum of 50 elective/emergency cases/annum
within the emergency PPCI site.
The multidisciplinary team
International guidelines recommend the utilisation of multidis-
ciplinary teams to guide the management of patients with cor-
onary artery disease.1 2 Careful discussion about the pros and
cons of medical therapy versus revascularisation whether with
surgery or PCI is accepted best practice. The detailed function-
ing of such a ‘Heart Team’ varies across the UK as does its com-
position, frequency and the type of cases discussed.
In 2013, the BCS, the BCIS and the Society for Cardiothoracic
Surgery commissioned a joint working group. Its task was to
produce a document with the intention of providing guidance as
to the essential components of a Heart Team in terms of how it
should be structured and how it should function.19 The complete
document can be accessed on the websites of all three societies
(http://www.bcis.org.uk, http://www.bcs.com and http://www.
scts.org). This includes its attendance, scheduling and frequency
as well as the type of cases to be discussed and the minimum data
to be presented. Importantly, it also addresses the required man-
agerial, administrative and technological support, systems of
documentation, feedback and audit, and the degree and timing
of patient/carer involvement.
Key areas include:
A. Patient and carer involvement
The patient’s presence at the multidisciplinary team (MDT)
meeting is usually impracticable. Thus a Clinician, who is famil-
iar with the case and is able to represent the patient’s best inter-
ests and any declared wishes, should attend. Facilitated by the
coordinator, it should be that clinician’s responsibility to ensure
that the patient is advised of the MDT’s recommendations. In
elective cases, that transfer of information should be undertaken
in an outpatient setting which will also present an opportunity
to initiate the consenting process.
In cases of equipoise, that is, the evidence for one manage-
ment strategy is balanced by that for another, this should be dis-
cussed with the patient in order to gauge their own preference.
A Clinician of any of the specialties represented at the MDT
should undertake that discussion emphasising the positive
aspects of having more than one treatment available, rather than
giving the impression of clinical indecision.
B. Clinical composition and frequency
The MDT should be chaired by a consultant and comprise a
minimum of an interventional cardiologist, a cardiac surgeon and
ideally a non-interventional cardiologist in order to be quorate.
A clinical individual who is familiar with the case, and is dir-
ectly responsible for that patient’s care, should present the data
related to each patient to be discussed.
MDT meetings should be held at least once per week and at
least 1 h should be allocated.
C. Facilities and technical considerations
MDT meetings should be held in a dedicated room that offers
privacy and space for attendees. Patient imaging should be
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displayed on screens offering diagnostic medical quality and be
visible to all attendees. IT support should ensure that images
from remote centres can also be viewed and that where neces-
sary two-way voice communication with referral units can be
accomplished during the meeting. It should be available during
the meeting if required in order to deal rapidly with any tech-
nical problems.
D. Administration and managerial support
A dedicated MDT coordinator should be present in order to (1)
assimilate patient information prior to the MDT meeting, (2)
document attendance; (3) record recommendations in each case,
and (4) facilitate communication of that decision to all relevant
parties.
In cases in which decision-making is not straightforward the
essential elements of the discussion should also be recorded.
The MDT recommendations, as well as any additional informa-
tion where relevant, should be recorded by the coordinator and
signed by the Chair.
E. The type and range of cases to be discussed
MDT discussion should be considered routine when diagnostic
angiography reveals a left main stem stenosis or obstructive mul-
tivessel coronary disease, and there is no clinical mandate to
proceed immediately to PCI. This is particularly relevant for
patients in which revascularisation is considered high risk or
highly complex including most patients with a chronic total
occlusion. There may be occasions when clinical circumstances
do not allow time for discussion in a formal MDT setting. In
such cases ad hoc discussions will take place, the essence and
outcome of which should be documented into the case notes.
F. Minimum data discussed and method of presentation
Clinical data, significant comorbidity and the results of all rele-
vant investigations should be made available to the MDT coord-
inator prior to the meeting. Patient data should be presented to
the MDT by the clinician familiar with the patient and their
wishes with regards to possible management plans.
A recognised scoring system should be used in evaluating the
procedural risk of either CABG or PCI. In addition the
SYNTAX score could also be calculated and used in order to
inform the discussion as to the burden of disease.20
G. MDT considerations and functioning in non-surgical centres
The principles of MDT structure and functioning apply to non-
surgical cardiology units to the same extent as they do to
cardiac surgical centres.
MDT meetings should occur with the same frequency and
timing in non-surgical centres as in surgical units.
In order to ensure that all relevant specialties are represented,
clinicians may have to travel between units to attend meetings.
If this is considered to be impractical then teleconferencing
technology is recommended and should be supported by the
respective Trusts.
H. Timing and integration within job planning
MDT meetings should be scheduled during working hours.
Job planning for consultant staff should incorporate their
attendance at MDT meetings.
I. Documentation, feedback and audit of outcomes
The outcome of MDT meetings and their recommendations in
each case should be documented and signed by the Chair. In
situations in which the discussion is not straightforward those
particular elements that have led to the eventual recommenda-
tion should also be documented accurately and signed by the
Chair. This applies particularly to cases that are judged to be at
increased risk for either CABG or PCI. In addition to recom-
mending the need and mode of revascularisation, the MDT
should also indicate the priority in each case.
Units should put in place a system in which cases discussed in
an MDTare followed up to ascertain whether the recommenda-
tions made were carried out. If there is any aberration then the
reasons for this should be discussed and documented in the
patient’s medical records and then rediscussed at the MDT.
Key points: MDT
▸ The MDT should comprise a minimum of an interventional
cardiologist, a cardiac surgeon and a non-interventional
cardiologist in order to be quorate.
▸ A clinical individual who is familiar with the case, and is
directly responsible for that patient’s care, should present
the data related to each patient to be discussed.
▸ Job planning for consultant staff should incorporate their
attendance at MDT meetings.
MONITORING STANDARDS
Audit
All PCI centres are expected to collect comprehensive and
accurate data that relates to the interventional treatment they
provide for their patients. This includes information pertaining
to the structure of service provision, the appropriateness of
intervention, and the process and outcomes of PCI. The data
are expected to relate to each PCI centre (and not combinations
of centres even if within a single trust).
BCIS provides a clinical data set to allow a national compari-
son of results of interventional techniques and comparative
audit.21 This data set is updated periodically to remain pertinent
to current therapeutic strategies. Structural changes to the data
set are made as infrequently as possible to minimise disruption
to the data collection infrastructure, but more frequent updates
are made to the libraries of device names and medications. It is
expected that changes to the BCIS data set can be implemented
within a notice period of 3 months. Definitions of the variables
are contained within the data set document which takes the
form of a spreadsheet and is available on the BCIS website.
BCIS oversees and guides the collection and analysis of these
data which is currently hosted by the NICOR.
It is the responsibility of the Trust/Hospital to provide the
appropriate audit and information technology infrastructure to
allow clinicians assisted by data managers to collect comprehen-
sive and accurate data and to achieve data submission that com-
plies with deadlines set by BCIS and NICOR to permit data
analysis and presentation within the required timescales each
year.
Each cardiology department should provide the name of a
designated clinician to lead the audit process and ensure that
the infrastructure is in place. However, the ultimate responsibil-
ity for data completeness and accuracy rests with the consultant
PCI operator responsible for the PCI procedure.
External data validation is not currently possible. It is there-
fore recommended that regular internal validation of case ascer-
tainment, data completeness and data accuracy is performed.
This is particularly recommended for the date/time fields for
patients treated by PPCI and in the adjudication of high risk
clinical features. An annual internal review of cardiogenic shock
outcomes and data entry is especially recommended to ensure
consistency and accuracy.
The BCIS data set requires that information be collected from
symptom presentation through to discharge from that PCI
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centre. Systems to collate and record events, particularly those
that occur after a patient leaves the interventional lab require
organisation and funding. Audit to ensure the completeness and
accuracy of these processes should be performed locally.
Outcome data which pertains to catheterisation laboratory dis-
charge alone is insufficient.
Recommendations for data collection and submission apply
to NHS and private centres.
Institutional audit and clinical governance
BCIS reports the results of an analysis of UK-wide PCI activity
on an annual basis. The information is made available on the
BCIS website for download. These data can be used by individ-
ual PCI centres to assess trends and to benchmark their own
activity. Internal presentation of a PCI centre’s outcomes and
their relative performance against the national data is recom-
mended on an annual basis.
In addition it is recommended that there is regular review of
each PCI centre’s practice against established national and inter-
national guidelines including National Institute for Health and
Care Excellence (NICE), the ESC and AHA as deemed applic-
able to UK practice. Regular discussions should include individ-
ual case presentations for all unexpected mortality and
morbidity. Additional audit of other complications and, for
example, complex patient or complex lesion subsets are recom-
mended. It is expected that Trusts will provide appropriate
support for this process of clinical governance to allow collation
and analysis of these data, ring fenced time for audit meetings,
facilities for presentation, and support so that the meeting out-
comes can be formally minuted and these minutes archived.
The specifics of the practice of institutional audit vary consid-
erably around the country. Examples of good practice include
random review of individual cases by randomly allocated collea-
gues and presentation of the case.
Individual operator outcomes
BCIS in collaboration with NICOR, will provide all individual
operators with a detailed breakdown of their own PCI activity
that includes process control charts and risk-adjusted outcome
analysis. The aim is to provide data for each PCI operator that
can be used in the process of annual appraisal and revalidation.
Public reporting
BCIS, in collaboration with NICOR, will provide a set of ana-
lyses at institutional and individual operator levels intended to
be understood by the general public. This process started in
2013, with the intention of providing 3-year rolling data in the
future. Overall numbers of PCI procedures, a split by clinical
syndrome and risk-adjusted outcomes will be presented in the
first instance.
Key points: monitoring institutional standards
▸ All PCI centres are expected to collect comprehensive and
accurate data that relate to the interventional treatment they
provide for their patients.
▸ Regular departmental discussions should include individual
case presentations for all unexpected mortality and
morbidity.
▸ BCIS will provide operators with a detailed breakdown of
their own PCI activity that includes risk-adjusted outcome
analysis.
ANNUAL APPRAISAL AND REVALIDATION
The results of individual operators are likely to be improved by
sharing experiences with colleagues. Discussion between opera-
tors, both formal and informal, should be part of departmental
meetings. Maintaining optimal clinical practice in coronary
intervention requires ongoing review of the medical literature.
An awareness of the evolution of technology and the availability
of adjunctive pharmacology is mandatory.
BCIS recommends a minimum of 4 days a year attending
national and international meetings relating to cardiovascular
intervention. A record of Continued Professional Development
using the Royal College of Physicians (RCP) website is recom-
mended. Demonstration of completion of local statutory man-
datory training along with demonstrable participation in quality
improvement process should be considered standard and be pre-
sented within the revalidation portfolio.
BCIS will provide their members who are individual opera-
tors with a detailed breakdown of their own PCI activity to be
used in the process of annual appraisal and revalidation.
NEW CENTRES
The development of a new PCI site should be agreed by Hospital
Trusts with all the relevant stakeholders through a strategic
plan developed with the local cardiac network. Stakeholders
include the local surgical centre, other nearby PCI centres, local
commissioners of healthcare and specialist commissioners.
Recommendations for the structure of a new PCI service are
available on the BCIS website and should be used as a guide.22
Once a service is prepared for clinical commissioning a
request should be made to the secretary of BCIS by the Chief
Executive of the Trust. This request should include a statement
confirming that the proposed PCI service will not begin until
BCIS approval for service initiation is obtained. The BCIS peer
review team will comprise two Interventional Cardiologists
from outside the region who will arrange a mutually convenient
time for the visit. It is expected that the visit will be arranged
within 8 weeks of the request and the BCIS team will expect all
of the documentation outlined on the website to be available
prior to the visit.
At the completion of the visit the BCIS representatives will
write a report and submit it through the Clinical Standards
Group to BCIS Council. This report is then returned to the
Trust Chief Executive with copies to the relevant Network and
NHS England.
Follow-up visits are not anticipated subsequent to the agree-
ment about the initiation of the service unless special circum-
stances apply.
TEACHING AND TRAINING
A training programme must ensure that its trainees acquire a
sound knowledge base of the basic principles that underpin the
practice of interventional cardiology. It is recommended that
training programmes have a core curriculum that covers at least
the following important topics:
▸ Anatomy and physiology pertaining to the cardiovascular
system.
▸ In particular the trainee needs to understand coronary
anatomy including its variations and congenital abnormalities,
cardiac haemodynamic function and coronary physiology.
▸ Pathophysiology of cardiovascular disease.
▸ Pharmacology principles to provide an understanding of car-
diovascular contrast agents and drugs commonly used for
invasive procedures.
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▸ Principles of haemostasis including indications for and com-
plications of vascular closure devices.
▸ Radiology imaging and radiation safety. This should include
design and operation of X-ray cine angiographic units, basic
radiation physics, radiation quality assurance, and an under-
standing of the biological risks from radiation exposure so as
to minimise radiation exposure to the patient and catheterisa-
tion laboratory staff.
▸ Knowledge of lesion assessment with quantitative coronary
angiogram analysis, physiological assessment and intracoron-
ary imaging.
▸ The design and performance of interventional devices.
▸ Clinical management strategies to include case selection, per-
formance of the procedures, and subsequent management of
the patient before discharge and beyond. A clear understand-
ing of the indications, limitations, and complications of the
procedures must be acquired.
Training in cardiac catheterisation
Before undertaking training in interventional cardiology the
trainee must achieve competence in general cardiology and in
diagnostic cardiac catheterisation. The trainee should have com-
pleted training in diagnostic cardiac catheterisation procedures as a
primary operator. These should include left heart catheterisation
and coronary arteriography, as well as graft studies. Before formal
training in intervention begins, the trainee is expected to have
assisted in at least 25 PCI procedures. Specialist training should be
the focus of the last 2 years in the SpR training programme.
Selection
Training institutions should have in place a method of formal
assessment and selection for the training places that can with-
stand fair scrutiny. The process of selection of an interventional
trainee differs between institutions with no agreed mechanism
nationally. Competitive interviews are recommended. After the
selection, ongoing formal assessment throughout the period of
training is mandatory with clear bidirectional feedback.
If it is considered that training would be appropriate for an
individual but local circumstances are such that the training
cannot be provided locally, an interdeanery transfer can be
considered.
Local arrangements with neighbouring centres should be
encouraged for trainees to be able to train in techniques not
available at the host institution.
Procedural numbers and scope
Defining the minimum number of PCI procedures that constitutes
an acceptable training in PCI remains difficult. A minimum of 200
procedures/year over the 2 years prior to consultant appointment
with at least 125 as the first operator is the minimum requirement.
During these cases the trainee must be fully involved in preproce-
dural evaluation of the patient, selection of equipment, discussion
of risk and benefits and the outcomes of each intervention. The
trainee should be directly involved in the reporting of the proced-
ure including completion of database archiving, and documenta-
tion of any complications up to the time the patient is discharged
from hospital. A review of the trainee’s experience and outcomes
should be performed on a regular basis.
Practical skills should be assessed on a competency basis.
Completion of a logbook is mandatory for practical procedures
along with completion of existing educational assessments.
Observations by the educational supervisor and by a consultant
other than the educational supervisor will be part of the assess-
ment methods.
The training should have the following components:
▸ Core procedures including vascular access and vascular access
management—including both radial approach and femoral
approach.
▸ Conventional balloon angioplasty.
▸ Coronary artery stenting.
▸ PCI in the setting of ACS including primary intervention for
STEMI.
▸ Pericardial aspiration.
▸ Intra-aortic balloon counterpulsation and other techniques of
mechanical circulatory support.
▸ Intracoronary imaging.
▸ Coronary flow measurements/pressure wire measurements.
▸ Use of protection devices.
▸ Use of techniques to treat coronary perforation.
Experience in other techniques would depend on the expertise
and practice of the institution. These could include
post-Cetrificate of Completion of Training (CCT) training in the
following:
▸ Rotational atherectomy
▸ Embolisation devices (eg, coils)
▸ Intravascular foreign body retrieval
▸ Adult structural heart intervention including:
– Balloon valvuloplasty.
– Transcatheter aortic valve implantation.
– Transcatheter closure of congenital/acquired defects.
– Left atrial appendage occlusion.
For the purpose of training it should be left to the trainer to
determine when a trainee has been the principal (first) operator.
The trainee must personally perform the procedures under the
direct supervision of a recognised trainer. The trainer who takes
overall responsibility for the patient must be immediately avail-
able in the catheterisation laboratory to supervise the trainee.
Trainees should be exposed to a comprehensive range of
patient mix and these should include patients with stable angina
and ACS such as unstable angina, acute MI and cardiogenic
shock. All trainees should be able to acquire significant experi-
ence in the management of patients who require circulatory
support, particularly with intra-aortic balloon counterpulsation.
Trainees must be familiar with the BCIS/ Central Cardiac
Audit Database (CCAD) audit requirements for PCI and be
aware of and participate in data collection and validation.
Education
BCIS recommends that an interventional training programme
should hold a regular interventional meeting. This should
address the core curriculum subject matter and should provide
an opportunity to review both the diagnostic and interventional
cases with respect to patient selection, the performance of the
procedure, clinical outcome and any complications. The MDT
meeting as an integral part of decision making should have
active involvement of the interventional trainees.
Participation in clinical research by the trainees should be a
core requirement for the programme. Trainees should be encour-
aged to initiate individual research and participate in trials in
which the institution is taking part. Trainees should be active par-
ticipants in data analysis and presentations and be encouraged to
undertake clinical audit and follow-up of patients.
Trainees should spend at least 4 days each year attending
appropriate educational meetings. Participation in the BCIS
Basic Cardiovascular Intervention Course, The Advanced
Cardiovascular Intervention Course for Trainees and annually the
Advanced Cardiovascular Intervention are strongly recommended.
Further relevant opportunities for education come in the form of
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international Fellows Courses, and the two major international
meetings (Euro-PCR and Transcatheter Therapeutics meeting
(TCT)).
Trainers
Each institution with an interventional training programme
should have at least three experienced clinical Interventional
Cardiologists who have each performed a minimum of 500 pro-
cedures in their careers. Each centre will have a designated train-
ing programme Director who will ensure trainee selection,
appraisal and assessment. The programme director should have
a career experience of a minimum of 1000 coronary interven-
tional procedures. An interventional training centre will
perform a minimum of 400 PCI procedures a year to allow a
trainee to participate in the full spectrum of coronary interven-
tion. We recommend that the number of trainees accepted into
a training programme should reflect the institutional volume
and the number of senior trainers available. Generally a PCI
programme should be an integral component of a comprehen-
sive service and should have on-site capabilities including a cor-
onary care unit, cardiac surgery, cardiac intensive care and
cardiac imaging including echocardiography, cardiac magnetic
resonance scanning and nuclear cardiology.
High volume PCI programmes without on-site cardiac
surgery provide excellent PCI training and training in these
centres should be considered as an equivalent to training in a
surgical centre. However it is expected that trainees will spend
time training within a surgical centre, and that arrangements are
made to allow interaction with neighbouring on-site surgical
centre interventional trainers, trainees and cardiac surgeons.
Trainee evaluation
The responsibility for trainee evaluation should reside with the
Programme Director for Education. Regular review of the trai-
nee’s feedback along with trainer’s feedback, and presentation
of that within the Deanery should occur on an annual basis.
The programme director should be responsible for confirming
that trainees have completed their interventional training satis-
factorily as required by the core training requirements.
FUTURE DEVELOPMENTS
Commissioning
The RCP/BCS response to the NHSWhite Paper Equity and excel-
lence: liberating the NHS,23 is endorsed by BCIS including liaison
at local vascular/chronic disease management board level between
the local cardiology service and primary care clinical commission-
ing groups. The new Cardiovascular Disease Outcomes Strategy
2013 emphasises agreed care pathways for cardiac conditions
across the local health economy.24 NHS England and clinical com-
missioning groups have committed to reviewing, through the spe-
cialty’s clinical reference group and local senates/networks,
achievements in national cardiac audits including the NICOR,
together with local mortality trends, in setting its priories.
Cardiovascular networks are recognised to have an important
relationship with commissioning and PCI has shown the efficacy
of that in the roll-out of network-based PPCI. Service level
agreements should reflect expected outcomes to meet national
cardiac audit outcomes. These key points for commissioners
have been taken from the RCP’s Consultant physicians working
with patients: The duties, responsibilities and practice of physi-
cians in medicine.25 Further information on service organisa-
tion, workforce requirements and job plans for cardiology
services can also be found in this document.
New technology
Interventional cardiologists use and manage a very wide range
of medicines and medical devices. Within the UK, the MHRA is
responsible for regulating all medicines and medical devices by
ensuring their safety and efficacy. The MHRA is a centre of the
Medicines and Healthcare Products Regulatory Agency which
also includes the National Institute for Biological Standards and
Control (http://www.nibsc.org/) and the Clinical Practice
Research Datalink (http://www.cprd.com/). The MHRA is an
executive agency of the Department of Health. Its role includes
guidance, safety alerts and links to educational material to assist
cardiology practitioners in the safe use and management of
medicines and medical devices.
NICE provides national guidance and advice to improve
health and social care. NICE was originally set up in 1999 as
the National Institute for Clinical Excellence, and in 2005, after
merging with the Health Development Agency, the name
changed to the National Institute for Health and Clinical
Excellence. At this time NICE took on responsibility for devel-
oping guidance and quality standards through the work of inde-
pendent committees. NICE currently provides guidelines,
technology appraisals, guidance on interventional procedures,
new medical technologies and use of diagnostic techniques.
These currently include guidelines on the use of drug-eluting
stents for patients with coronary artery disease.
Research
Research is a fundamental part of interventional cardiology
and its scope goes beyond the limits of this document. The
UK has a prominent role in interventional research and this is
important for patients, interventional teams and the broader
NHS. BCIS supports research in a number of ways which
include the R&D group which has as its primary goal the
promotion of interventional research in the UK. The core
philosophy is that the best research is planned, conducted and
reported by motivated teams that ‘own’ the project. The BCIS
R&D committee seeks to facilitate the regular performance of
quality, perhaps collaborative, studies in centres that have not
previously regarded this as core business, or who have
perhaps been overlooked when research organisations select
partners.
BCIS also encourages the use of the BCIS audit data set for
observational research, and this has resulted in a number of pub-
lications. Applications to use the data set for research can be
made via the NICOR website.
Within the UK the National Institute for Health Research
Clinical Research Network (NIHR CRN) provides health
service infrastructure (eg, research support staff such as clin-
ical research nurses; and research support services such as
pharmacy, pathology and radiology) to support clinical
research in the NHS in England. The NIHR CRN comprises
15 local CRNs and a national coordinating centre whose
purpose is to provide efficient and effective support for the
initiation and delivery of funded research in the NHS. Some
of this research is funded by the NIHR, but most of it is
funded by NHS non-commercial partners and industry. This
activity makes an important contribution to improve the
health of the population and to support economic growth;
and the NIHR CRN features in the government’s Strategy for
UK Life Sciences.
The NIHR CRN allocates and manages funding to meet NHS
support (eg, additional nursing time; pathology sessions; lab
costs; imaging; additional outpatients costs) for eligible studies.
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These comprise randomised controlled clinical trials of interven-
tions (including prevention, diagnosis, treatment and care) and
other high quality well designed studies. The website http://
www.crncc.nihr.ac.uk provides the criteria governing eligibility
of studies for Network support.
BCIS meetings and live cases
BCIS has a major role in training and education, with annual
Society meetings and contributions to other national and inter-
national forums. These meetings may include lectures and
debates, case-based discussions, angiogram review sessions, and
live case demonstrations to exhibit procedural techniques and
new technologies. Specifically BCIS provides two specialist inter-
ventional training courses/year together with an annual
Advanced Cradiac intervention (ACI) meeting and a rotating
autumn meeting.
Audiences at these meetings may include medical and non-
medical clinicians; members of the medical technology, device and
pharmaceutical industries; members of government agencies or
other professions; patients and their representatives; and members
of the general public. Presentations may also include discussion of
complications of cardiac interventions that cause morbidity and
mortality. Critical review of these cases is an essential component
of audit and education, and should be conducted in a supportive
atmosphere to ensure that colleagues remain willing to present fail-
ures as well as successes. Attendance and participation by interven-
tionalists at these meetings is very strongly encouraged and is a
fundamental part of the revalidation process.
BCIS wishes to ensure that participants in all of these activities
adhere to the highest standards of professional practice and that
the care and dignity of patients is maintained. The link http://
www.bcis.org.uk/resources/C28_BCISRecommendationFPB pro-
vides the guidelines for the conduct of BCIS members at meeting
and for the conduct of live cases.
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APPENDIX 1: LEFT MAIN STEM DISEASE
There is a very extensive literature of observational and rando-
mised trials that have evaluated revascularisation in patients
with left main disease. This literature has been extensively sum-
marised in the 2014 ESC and the 2011 ACCF/AHA/SCAI
guidelines.1 14
In the pre percutaneous coronary intervention (PCI) era, cor-
onary artery bypass grafting was the only option available for
revascularisation in patients with significant left main disease.
Subgroup analyses from the CASS registry and meta-analysis of
several randomised controlled trials (enrolling a total of >2500
patients) indicated that, when compared with what we would
now consider to be inadequate medical therapy, coronary artery
bypass grafting (CABG) significantly improved survival in these
patients. Multiple trials have reported on outcomes comparing
CABG and PCI for the treatment of left main coronary disease.
A recent meta-analysis of over 14 000 patients enrolled in com-
parative trials of the two techniques reported no significant dif-
ference for all-cause mortality over a 5-year follow-up period.26
Recurrent ischaemia and repeat revascularisation procedures
were significantly more common in patients undergoing PCI for
left main disease compared with CABG. The occurrence of
stroke was less frequent in patients treated with PCI.
The most reliable contemporary data comparing PCI with
drug-eluting stents or CABG for left main coronary disease is
provided by the SYNTAX trial.27 In SYNTAX, 705 of the 1800
patients randomised had left main coronary disease. When the
patients were grouped according to a measure of the complexity
and extent of their coronary disease, using the SYNTAX score, a
clear pattern emerges. In patients with less complex disease (low
or intermediate SYNTAX score) CABG confers no survival
advantage over PCI. For patients with more complex disease
(manifest as a SYNTAX score greater than 33) CABG reduces
mortality by a considerable extent.
Performing PCI in the left main stem should always be
regarded as a challenging procedure. Operators and their cath-
eterisation laboratory teams need to be experienced and profi-
cient in rapidly responding to a sudden unplanned deterioration
and the requirement for complex bailout stenting strategies. In
some circumstances, rapid and effective deployment of haemo-
dynamic support devices can be life-saving. It is important that
these are immediately available and can be inserted and acti-
vated rapidly
Adherence to these standards will provide the best chance of
a good patient outcome. The documented outcomes reported in
the literature have been obtained by expert PCI teams. In cir-
cumstances when these minimal standards cannot be met, alter-
native referral is advised to a suitably equipped and experienced
interventional colleague/centre. Preprocedural planning in left
main stem cases requires multidisciplinary team (MDT) discus-
sion and then careful evaluation, and this usually extends
beyond the basic information provided by angiography alone.
Preprocedure including intravascular ultrasound (IVUS) and/or
measurement of fractional flow reserve is recommended to char-
acterise the anatomical and haemodynamic features of the
lesion, and guide stent sizing and procedural technique. There is
often considerable difficulty in optimally sizing stents, and IVUS
or optical coherence tomography should be performed after
stent deployment to ensure that a good result with optimal stent
apposition has been obtained.
In many patients with left main disease coronary calcification
is common and the potential for adjunctive plaque modification
to facilitate optimal stent implantation is high. This may not
always be readily apparent on angiography, further emphasising
the value of IVUS for preprocedure planning. Centres and
operators performing left main intervention should ensure that
they are proficient in the use of rotational atherectomy, and that
this is available when performing urgent/elective PCI to the left
main coronary.
Key points: left main coronary intervention
▸ When patients present with coronary instability associated
with a culprit lesion in the left main, reduced antegrade
coronary flow and clinical instability, PCI should be
considered if the patient’s clinical condition precludes
performing CABG.
▸ In more stable patients, discussion by a multidisciplinary
team is the recommended way of selecting an optimal
revascularisation strategy.
▸ Availability of intra-aortic balloon counter-pulsation pump
(IABP), IVUS, rotational atherectomy, and pressure wire
systems are mandatory for left main intervention procedures
along with the necessary expertise.
APPENDIX 2: CHRONIC TOTAL OCCLUSIONS
Chronic total occlusions (CTOs) are identified in up to a third of
coronary angiograms28 but are relatively under-represented in per-
cutaneous coronary intervention (PCI) practice. CTOs were
approached in only 5% of all PCIs and in 15% of stable cases in
the UK in 2012.12 Reasons for this imbalance may include lower
PCI procedural success rates, perceived or real superiority of surgi-
cal revascularisation, or an assumption that medical therapy alone
is the only option for all but the simplest CTO lesion. However,
surgical success is not assured for CTOs—only 68% of CTOs were
successfully bypassed in the Syntax Trial29 and success rates for PCI
of 85% have been reported by CTO operators in Europe.30
High reported success rates for CTO PCI are likely to be
related to development of more complex techniques, such as the
retrograde approach and dissection/re-entry, in addition to
improvements in specific procedural tools, for example, dedi-
cated CTO wires, microcatheters (eg, Corsair, Tornus) and spe-
cialised re-entry equipment (Crossboss catheter, stingray wire
and stingray balloon). For complex cases and techniques, it
seems highly likely that case volume will have a part to play in
predicting success.
Although observational data exists suggesting prognostic gain
from CTO PCI,31 no randomised trial data exist which
12 Banning AP, et al. Heart 2015;101:1–13. doi:10.1136/heartjnl-2015-307821
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demonstrate improvement in prognosis. The primary indication
for CTO PCI therefore remains symptomatic improvement.
Patients should be established on optimal medical therapy
before being scheduled for PCI, but the bar need not be set
higher than for other patients with stable angina and there is no
requirement for multiple antianginals in maximum doses before
PCI is considered.
Ad hoc PCI for CTOs should not be performed. It is recom-
mended that angiograms in which a CTO is identified are pre-
sented to a multidisciplinary team (MDT). This should act as a
safeguard against inappropriate conservatism and ensure that
the most appropriate form of revascularisation is selected
according to patient and anatomical factors.
Information presented to the MDT should include: symptom
burden; current medical therapy; results of non-invasive tests
for viability and ischaemia; comorbidities which may affect the
safety of PCI (especially chronic kidney disease, peripheral vas-
cular disease and conditions which might limit the safe use of
DES). J-CTO score, Syntax score and Euroscore II should be
calculated and recorded.
Several anatomical factors have been identified which predict
CTO PCI success in contemporary practice and these have been
incorporated into the J-CTO score.32 Low J-CTO scores are
highly predictive of rapid antegrade wire crossing and ultimate
case success and therefore may assist in determining the setting
in which PCI is to be performed.
According to local practice, cases with J-CTO score of 0 in
whom rapid antegrade wiring is considered likely may be reasonably
treated by either ‘non-CTO operators’ or indeed by CTO teams.
Since success is not assured and complications are higher with
more complex techniques, all but the simplest ( J-CTO score 0)
cases should be performed by dedicated CTO operators in
centres with appropriate facilities.1 Dedicated CTO operators
should have the full skill set to escalate from simple antegrade
wiring to retrograde and dissection/re-entry at the same sitting.
Dual arterial access is strongly encouraged unless no contralat-
eral filling of the CTO vessel is seen.
A full range of equipment—including a range of CTO wires,
short guide catheters for retrograde access, microcatheters, small
over-the-wire balloons, snares, including intravascular ultrasound
(IVUS) and catheter extension devices—should be available and
the operator should be familiar with it. Emergency bailout kit
should be immediately available in the catheter lab—echocardiog-
raphy, pericardiocentesis and microvascular coils for perforations.
Adequate time should be set aside in the lab schedule to
perform CTO PCI, which may be lengthy. Dual operator cases
may be advantageous, especially with the most complex lesions
including reattempts. Operators should liaise with local radi-
ation protection advisors in order to set dose reference levels
for CTOs. Close attention should be paid to radiation protec-
tion measures for operators—eye shields, table skirts, eyewear
and disposable protection drapes should be available.
Angiographic views should be altered during long cases and
repeat procedures should be staged to reduce the risk of loca-
lised skin damage to patients. Ensuring patient safety is para-
mount and complex CTO procedures should always be
performed in centres where colleagues with appropriate CTO
experience are available to assist. Operators should carefully
consider whether a complex CTO case would be most safely
performed in a site with on-site cardiac surgery.
Restenosis is more common in CTO cases, at least partly
related to the common requirement for long segment coverage.
Drug-eluting stent use should therefore be the routine so an
assessment of likely tolerability of prolonged dual antiplatelet
therapy (DAPT) is required. Potential problems with DAPT
should be highlighted and discussed at MDT.
Key points: Ad hoc CTO PCI should not be performed
▸ All CTOs should be discussed at MDT regardless of initial
intended therapy.
▸ Complexity scoring of the CTO is recommended for all cases.
▸ All complex cases should be discussed with and/or
performed by dedicated CTO operators.
▸ Drug-eluting stent use is strongly encouraged.
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